22
Views
13
CrossRef citations to date
0
Altmetric
Review

Atypical antipsychotics: revolutionary or incremental advance?

&
Pages 69-88 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Leslie Citrome & Betty Vreeland. (2008) Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?. Postgraduate Medicine 120:2, pages 18-33.
Read now
Leslie Citrome, Joseph F. Goldberg & Stephen M. Stahl. (2005) Toward Convergence in the Medication Treatment of Bipolar Disorder and Schizophrenia. Harvard Review of Psychiatry 13:1, pages 28-42.
Read now
Leslie Citrome & Jan Volavka. (2004) The promise of atypical antipsychotics. Postgraduate Medicine 116:4, pages 49-63.
Read now
Leslie Citrome & Jan Volavka. (2002) Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current Evidence. Harvard Review of Psychiatry 10:5, pages 280-291.
Read now

Articles from other publishers (9)

Leslie Citrome & Jan Volavka. (2021) Specific Anti-hostility Effects of Atypical Antipsychotics in Persons with Schizophrenia: From Clozapine to Cariprazine. Harvard Review of Psychiatry 29:1, pages 20-34.
Crossref
Leslie Citrome, Lawrence Blonde & Cristina Damatarca. (2005) Metabolic Issues in Patients with Severe Mental Illness. Southern Medical Journal 98:7, pages 714-719.
Crossref
Leslie Citrome. (2004) Re: Treatment Noncompliance with Orally Disintegrating Olanzapine Tablets. The Canadian Journal of Psychiatry 49:6, pages 412-413.
Crossref
Stephen Gough & Robert Peveler. (2018) Diabetes and its prevention: Pragmatic solutions for people with schizophrenia. British Journal of Psychiatry 184:S47, pages s106-s111.
Crossref
Zhongyun Zhao, Madhav Namjoshi, Beth L Barber, Danielle L Loosbrock, Sandra L Tunis, Baojin Zhu & Alan Breier. (2004) Economic Outcomes Associated with Switching Individuals with Schizophrenia Between Risperidone and Olanzapine. CNS Drugs 18:3, pages 157-164.
Crossref
Sandra L Tunis, Haya Ascher-Svanum, Michael Stensland & Bruce J Kinon. (2004) Assessing the Value of Antipsychotics for Treating Schizophrenia. PharmacoEconomics 22:1, pages 1-8.
Crossref
Tami L. Mark. (2004) Preferences among antipsychotic medications given particular clinical scenarios. Schizophrenia Research 66:1, pages 71-73.
Crossref
Valentinas Maciulis, Istvan Bitter, Raimundas Milasiunas, Algirdas Dembinskas, Liaudminas Radavicius, Algirdas Kaunas, Martin Dossenbach & Daniel Walker. (2004) Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study. Current Therapeutic Research 65:1, pages 57-69.
Crossref
LESLIE CITROME, ROBERT M. BILDER & JAN VOLAVKA. (2002) Managing Treatment-Resistant Schizophrenia: Evidence from Randomized Clinical Trials. Journal of Psychiatric Practice 8:4, pages 205-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.